3-Allyl-5-(Z)-arylidene-2-thiohydantoins 8a-f were synthesized from the direct condensation of the aromatic aldehydes 7a–f with 3-allyl-2-thiohydantoin (6), which in turn was prepared from the reaction of glycine and allyl isothiocyanate. The alkylation of 8a–f with alkyl bromides 9a, b gave 3allyl-5-(Z)-arylidene-2-(alkylmercapto)hydantoins 1a–1, S-Glycosylation and S-ribosylation took place on the reaction of 8a–f with pyranosyl bromides 11a, b and furanosyl bromide (15) under anhydrous alkaline conditions. The S-nucleoside structure, and not that of the N-nucleoside isomer, has been selected for the products. This structure has been confirmed from a model study of the coupling of 8a with α-D-glucose pentaacetate (13) and α-D-ribose tetrabenzoate (16) under Lewis acid conditions. The compounds do not display any antiviral and antitumoral activity.
No takes yet. Share an insight, caveat, or question.
Khodair et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: